Résultats de la recherche

  • Flux RSS
(1 - 20 of 190)

Pages

MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease?
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
Atypical forms of optic neuritis.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
Current and future treatment approaches for neuromyelitis optica.
Deux nouveaux traitements par voie orale dans la sclérose en plaques rémittente [= Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Editorial [= Editorial]
Patient perceptions of multiple sclerosis and its treatment.
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Spasticité et vie quotidienne dans la sclérose en plaques [= Spasticity and everyday life in multiple sclerosis]
Ocrelizumab for the treatment of multiple sclerosis
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.
Impaired mental simulation of specific past and future personal events in non-depressed multiple sclerosis patients
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Mydriase unilatérale révélant une neuroborréliose de Lyme [= Unilateral mydriasis in Lyme neuroborreliosis].
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

Pages

Islandora displays